Bioequivalence

Bioequivalence is a pharmaceutical equivalence criterion based on the absence of a statistically significant difference between two drug formulations in the rate and extent of active pharmaceutical ingredient bioavailability at the site of drug action.

1.9K

Publications

69.9K

Citations

7.1K

Authors

1.9K

Institutions

Publications per year

2017–2026

286

Authors

7.1K

  1. SC
    Shein‐Chung Chow

    Duke University, United States

    39 publications · 1.4K citations

    23

    h-index

  2. LE
    László Endrényi

    University of Toronto, Canada

    34 publications · 980 citations

    20

    h-index

  3. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    23 publications · 3.4K citations

    18

    h-index

  4. WW
    Walter W. Hauck

    Thomas Jefferson University, United States

    23 publications · 1.7K citations

    18

    h-index

  5. LT
    László Tóthfalusi

    Semmelweis University, Hungary

    18 publications · 533 citations

    15

    h-index

1–5 of 7.1K

Venues

  1. Pharmaceutical Research

    68 publications · 4K citations

    35

    h-index

  2. PubMed

    Repository · 129 publications · 3.7K citations

    32

    h-index

  3. The Journal of Clinical Pharmacology

    81 publications · 2.6K citations

    30

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 39 publications · 1.6K citations

    24

    h-index

  5. Journal of Pharmaceutical Sciences

    45 publications · 2.9K citations

    24

    h-index

1–5

See also

Bioequivalence

Evaluation

Core Methods

Regulatory Standards

Applications

Limitations